Getinge AB (GNGBY)
24.91
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Getinge Enterprise Value : 7.271B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 7.271B |
| October 07, 2026 | 7.271B |
| October 06, 2026 | 7.319B |
| October 05, 2026 | 7.269B |
| October 02, 2026 | 7.172B |
| October 01, 2026 | 7.164B |
| September 30, 2026 | 7.215B |
| September 29, 2026 | 7.197B |
| September 28, 2026 | 7.368B |
| September 25, 2026 | 7.180B |
| September 24, 2026 | 7.152B |
| September 23, 2026 | 7.222B |
| September 22, 2026 | 7.271B |
| September 21, 2026 | 7.152B |
| September 18, 2026 | 7.021B |
| September 17, 2026 | 7.101B |
| September 16, 2026 | 7.101B |
| September 15, 2026 | 7.149B |
| September 14, 2026 | 7.149B |
| September 11, 2026 | 7.063B |
| September 10, 2026 | 7.117B |
| September 09, 2026 | 7.233B |
| September 08, 2026 | 7.271B |
| September 04, 2026 | 7.346B |
| September 03, 2026 | 7.434B |
| Date | Value |
|---|---|
| September 02, 2026 | 7.345B |
| September 01, 2026 | 7.345B |
| August 31, 2026 | 7.459B |
| August 28, 2026 | 7.459B |
| August 27, 2026 | 7.482B |
| August 26, 2026 | 7.482B |
| August 25, 2026 | 7.482B |
| August 24, 2026 | 7.482B |
| August 21, 2026 | 7.482B |
| August 20, 2026 | 7.497B |
| August 19, 2026 | 7.500B |
| August 18, 2026 | 7.337B |
| August 17, 2026 | 7.327B |
| August 14, 2026 | 7.333B |
| August 13, 2026 | 7.289B |
| August 12, 2026 | 7.289B |
| August 11, 2026 | 7.308B |
| August 10, 2026 | 7.337B |
| August 07, 2026 | 7.299B |
| August 06, 2026 | 7.284B |
| August 05, 2026 | 7.325B |
| August 04, 2026 | 7.335B |
| August 03, 2026 | 7.307B |
| July 31, 2026 | 7.261B |
| July 30, 2026 | 7.235B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Xvivo Perfusion AB | 667.74M |
| Paxman AB | 71.82M |
| Enovis Corp. | 2.364B |
| Edwards Lifesciences Corp | 45.13B |
| IDEXX Laboratories, Inc. | 41.37B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 89.59M |
| Revenue (Quarterly) | 894.98M |
| Total Expenses (Quarterly) | 805.18M |
| EPS Diluted (Quarterly) | 0.3297 |
| Gross Profit Margin (Quarterly) | 49.35% |
| Profit Margin (Quarterly) | 10.01% |
| Earnings Yield | 4.21% |
| Operating Earnings Yield | 7.30% |
| Normalized Earnings Yield | 4.394 |